CSPC Innovation Pharmaceutical Co., Ltd. announced a private placement of A shares of par value of CNY 1 per share for the gross proceeds of not more than CNY 500 million on July 23, 2021. The pricing base date of the transaction is the first day of the issue period, and the issue price is not less than 80% of the average price of the company's stocks 20 trading days before the first day of the issue period. The transaction will include participation from not more than 35 investors.

The issue volume will not exceed 30% of total capital prior to issuance. The securities to be issued in the transaction are subject to 6 months lock-up period. The transaction has been approved at 11th meeting of the 5th directorate of the company and subject to approval from company's directorate, company's shareholders' meeting and Shenzhen Stock Exchange and registered by the China Securities Regulatory Commission.